The
focus shifts from calorie counting and gym routines to correcting insulin
resistance and stabilising blood sugar

India’s
chronic lifestyle disease management playbook has traditionally focused on
lifelong management through medicines and medical procedures. Patients are
advised to control their numbers, stay on medication, and accept metabolic
conditions as permanent. So much so that Type 2 diabetes is labelled as a
progressive disease, and diseases like NAFLD, PCOS are normalized – “Sabko hota
hai” is the verdict.

At
dLife, Founder & CEO Anup Singh and 
Chief Operating Officer Ira Sahay are openly challenging that assumption.
Singh, an alumnus of IIT Roorkee, himself is a Type 2 Diabetic since 2011 and
has not taken any medicines. Ms. Sahay reversed her own autoimmune disease –
membranous nephropathy – entirely through dietary modifications, though she was
told that six months down the line Kidney Transplant could happen. Five years
later, and she is still living with her original kidneys and no medicines.

We
Reverse, Or We Refund

Their
position is clear in WELLNESS circles, it is 
DISRUPTIVE. Lifestyle-driven metabolic conditions, they argue, are often
reversible when insulin resistance and nutritional triggers are addressed
correctly. This belief has shaped dLife’s journey since its inception in 2014,
when the platform began as  India’s first
structured low-carb communities tailored to Indian food habits, including
vegetarian diets. And now, the Largest Low Carb Ecosystem in the world.

What
sets the dLife model apart is the level of accountability Mr. Singh is willing
to attach to outcomes. The company’s Reverse or Refund commitment is
intentionally bold. In an industry where guarantees are rare, he has chosen to
lean into the promise rather than dilute it. dLife is here to DISRUPT the
Wellness sector, through the WE Reverse Or We Refund model, says Singh.

“Our
view is simple,” Mr. Singh says. “If the root metabolic dysfunction is
addressed and the protocol is followed sincerely, improvement should not be
optional. It should be expected. And if we are confident in the science, we
should be willing to stand behind it – 11 years of real-world data.”

TYPE
2 Diabetes is NOT A Progressive Disease. You have been lied to!

Diabetes,
everyone says, is a progressive disease. The real explanation for this is that
the A1C levels are criminally relaxed, and even an A1C of up to 7.5 on multiple
pills and even insulin is considered fine. No one tells a diabetic how to get
to an A1C of 5.6 max with minimal use of drugs and insulin.

Virtahealth
(USA) considers an A1C of 6.5 max, even with Metformin as REVERSAL.

If
your Fasting insulin is 10 or more, WE WILL REVERSE your TYPE 2 diabetes
or REFUND your money – dLife’s offer that’s going to DISRUPT the
wellness segment.

Sing
says, in 2011, when I told my endo that I would not take pills, but go on my
own protocol of 20:20:60 or 100gm/day max carbs, the endo said – You will die
of multiple organ failure.

He
retorts in a seriously funny way  – why
am I not dead? Haven’t visited a doctor since 2012. And, I am not alone. In 11+
years, thousands have reversed, if not lacs.

PCOS
Should Not Be Normalized. It’s 100% REVERSIBLE

Much
of dLife’s recent focus has been on conditions that are rising sharply among
younger urban populations. PCOS is one of the most prominent. The
organisation’s framework treats PCOS primarily as a metabolic and
insulin-driven disorder rather than viewing it only through a reproductive
lens. Programs emphasise high-protein, controlled-carbohydrate nutrition
alongside long-term lifestyle correction – again within the dLife’s proprietary
20:20:60 protocol

Mr.
Singh and Ms. Sahay often point to a recurring pattern they observe in
practice. Many women presenting with PCOS also show markers of insulin
resistance, weight fluctuation, or early metabolic dysfunction. Addressing
hormonal symptoms without correcting the metabolic base, they argue, often
leads to temporary relief rather than durable change. dLife also has successful
cases of endometriosis reversal, avoiding hysterectomy.

NAFLD
Should Not Be Normalized. It’s 100% REVERSIBLE

Fatty
liver and NAFLD management form another major pillar. Often called a silent
condition because patients may remain asymptomatic for years, fatty liver is
emerging as one of India’s fastest-growing metabolic risks. Approximately 40%
of Indians, including doctors, are suffering from NAFLD. dLife’s protocols
focus on visceral fat reduction, liver marker improvement, and sustained
nutritional correction. Here again, Mr. Singh’s stance is assertive. Grade 2
NAFLD, he maintains, fatty liver is  REVERSIBLE  with structured DIETARY intervention. WE
REVERSE or WE REFUND!

Weight
Loss Is a Collateral Advantage & Never The Target

Interestingly,
despite visible weight changes in many clients, the organisation does not
position itself as a weight-loss company. In Mr. Singh’s view, obesity is usually
a downstream effect of deeper metabolic imbalance rather than the primary
problem.

The
emphasis, therefore, is not on chasing the weighing scale but on correcting
insulin resistance, stabilising blood sugar, and restoring metabolic
flexibility. When insulin levels drop, and the body shifts from fat storage to
fat utilisation, visible weight reduction follows naturally. According to
dLife, targeting weight directly without addressing hormonal and metabolic
drivers often leads to cycles of temporary success and long-term relapse.

Correct
the underlying dysfunction, he argues, and weight tends to normalise as a
collateral outcome. Expensive GLP-1 drugs, they view as new FASHION and not a
necessity, as dLife’s 100 g/day max carbohydrate template (or 20:20:60 model)
dietary protocol gives the same results without the side effects.

Calorie
Counting, Portion Control, and Spending Life in the Gym Not Needed

This
philosophy shapes the program design. The dLife model does not centre on
calorie counting, excessive gym routines, or steep targets. Instead, the focus
remains on food quality, metabolic repair, and satiety-based eating patterns
intended to reduce what the company calls fall-off-track behaviour. To support
adherence, the platform has built an extensive low-carb Indian recipe
ecosystem, with 2000+ Indian low-carb and Keto recipes with macro and micro
breakdowns available for the clients

CICO
(Calorie In Calorie Out), is a Heads I Win, Tails You Lose Model, says
Singh. A FAILED MODEL that comes with renewal plans. So, don’t waste your
resources on the CICO approach. Never works in the long term. If it did, 40%+
of India wouldn’t be OBESE.

Building
an Army Of Metabolic Health Consultants – The Certification Course

Alongside
patient programs, dLife has expanded its professional ecosystem through the
dLife 5.0 framework. This includes consultancy, certification course – LOW CARB NUTRITION & METABOLIC HEALTH
with Dual Certification – , and Community – the 3C’s .

The
NSDC Partner certificate can be pulled into DIGILOCKER in Real Time. THE CPD SO
(UK) certificate comes with 158 hours of CPD credits, recognised in 50+ countries
globally. Overseas courses in the same segment have no legal tenability in
India. So no point wasting your money on such overseas courses.

The
aim is to build a wider network of trained Metabolic Health Consultants (with a
legally tenable certificate) who can apply metabolic correction principles in
real-world settings. Notably, many doctors trained through the system also
become partners for complex or resistant cases. Each case in the dLife network
is handled by two certified Metabolic Health Consultants and one
dLife-certified doctor.

Autoimmune
Disorders

The
organisation’s work is not limited to metabolic syndrome alone. Under Ms.
Sahay’s supervision, dLife also handles select autoimmune and complex metabolic
cases, broadening its positioning beyond conventional lifestyle coaching.

However,
the disease reversal under this doesn’t come with a REFUND guarantee.
Psoriasis, IBS/IBD, Urticaria, Ulcerative Colitis, Scleroderma, etc., have been
successfully reversed/improved quality of life. What’s more encouraging is that
many of these cases have been referred to by doctors themselves.

What
Next?

After
more than a decade in the space, Mr. Singh often describes dLife as a
destination many patients reach after trying multiple traditional routes. It is
a claim that carries both confidence and scrutiny. As India’s burden of
diabetes, PCOS, and fatty liver continues to climb, outcome-linked models like
dLife are likely to invite both attention and debate.

What
is clear is that Anup Singh and Ira Sahay are not attempting to quietly fit
into the existing metabolic care narrative through the CICO & Gym model.
They are attempting to challenge parts of it, and they are willing to attach
their credibility to the results.

To
begin your healing journey, book your virtual Discovery Call
as the first step or schedule a Walk-In Discovery call at:

dLife
HealthCare Pvt Ltd
1501, Morya Grand, Off New Link Road
Veera Desai Indl. Estate Road
Andheri (W)
Mumbai – 400058
Call: +91 9631570443

Follow
Anup Singh: https://x.com/dlifein
Follow Ira Sahay: https://x.com/TheIraSahay